[go: up one dir, main page]

RS20050835A - Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje - Google Patents

Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje

Info

Publication number
RS20050835A
RS20050835A YUP-2005/0835A YUP83505A RS20050835A RS 20050835 A RS20050835 A RS 20050835A YU P83505 A YUP83505 A YU P83505A RS 20050835 A RS20050835 A RS 20050835A
Authority
RS
Serbia
Prior art keywords
composition according
indion
group
release
agents
Prior art date
Application number
YUP-2005/0835A
Other languages
English (en)
Serbian (sr)
Inventor
Rajesh JAIN
Kour Chand JINDAL
Sukhjeet Singh
Original Assignee
Panacea Biotec Ltd.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd., filed Critical Panacea Biotec Ltd.,
Publication of RS20050835A publication Critical patent/RS20050835A/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YUP-2005/0835A 2004-01-06 2005-01-05 Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje RS20050835A (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN26DE2004 2004-01-06
IN24DE2004 2004-01-06
PCT/IN2005/000003 WO2005065640A1 (fr) 2004-01-06 2005-01-05 Nouvelles compositions pour formes posologiques orales, et procede de preparation de telles compositions

Publications (1)

Publication Number Publication Date
RS20050835A true RS20050835A (sr) 2007-08-03

Family

ID=34751866

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0835A RS20050835A (sr) 2004-01-06 2005-01-05 Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje

Country Status (2)

Country Link
RS (1) RS20050835A (fr)
WO (1) WO2005065640A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007096906A2 (fr) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Nouvelles compositions bucco-adhésives et procédé d'élaboration desdites compositions
CN100450548C (zh) * 2006-12-22 2009-01-14 江苏奥赛康药业有限公司 一种波拉克林树脂组合物的口腔贴片及其制备方法
WO2008155620A1 (fr) * 2007-06-20 2008-12-24 Develco Pharma Schweiz Ag Forme posologique contenant une matrice dispersible de granulés à libération entretenue
US8133506B2 (en) 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
EP3108876A1 (fr) * 2011-10-13 2016-12-28 Jaleva Pharmaceuticals LLC Procédés et compositions pour administration rapide d'agents actifs par la bouche
EP2906210A4 (fr) * 2012-10-12 2016-06-08 Jaleva Pharmaceuticals Llc Procédé de préparation de teintures de résine
EP2925273A4 (fr) 2012-11-28 2016-08-31 Jaleva Pharmaceuticals Llc Applicateur à deux chambres
CN105232502A (zh) * 2015-02-10 2016-01-13 万全万特制药江苏有限公司 含波拉克林钾和盐酸氟西汀复合物的口崩片及其制备方法
ES2983269T3 (es) * 2015-07-23 2024-10-22 Athena Pharmaceutiques Sas Composición de zolpidem y proceso de preparación de la misma
CN114344241B (zh) * 2021-12-15 2024-01-30 悦康药业集团安徽天然制药有限公司 一种聚丙烯酸树脂改性吸附药物载体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238072B (it) * 1990-01-19 1993-07-03 Sclavo Spa Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
AU3455297A (en) * 1996-07-11 1998-02-09 Farmarc Nederland Bv Pharmaceutical composition containing acid addition salt of basic drug
DE19932603A1 (de) * 1999-07-13 2001-01-25 Gruenenthal Gmbh Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
JP2004532838A (ja) * 2001-03-02 2004-10-28 ブリストル−マイヤーズ スクイブ カンパニー メラノコルチン受容体のモデュレーターとして有用な化合物及びそれを含む製薬組成物
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device

Also Published As

Publication number Publication date
WO2005065640A8 (fr) 2005-12-08
WO2005065640A1 (fr) 2005-07-21

Similar Documents

Publication Publication Date Title
JP5627455B2 (ja) 速崩性錠剤製造のための医薬製剤
EP1555022B1 (fr) Formulation d'acetaminophene et de tramadol a liberation prolongee
US20050250838A1 (en) Formulation for sustained delivery
CN101534792A (zh) 包含氧可酮的粒剂和口腔崩解片剂
JP2017206517A (ja) 薬物置換療法のためのブプレノルフィンウェハー
JP2011513391A (ja) ミコフェノラートを含有する徐放性医薬組成物およびその方法
CN103002882B (zh) 不含活性剂之颗粒及包含其之片剂的制备
JP2001172201A (ja) 経口投与形のための味をマスキングするコーティングとしてのフィルム被覆の使用、経口投与形及びその製造法
CN103002881B (zh) 载有活性剂的颗粒与额外活性剂的组合
JP2010529073A (ja) チュアブル錠及びトローチ剤製造のための医薬製剤
JPH05201866A (ja) 配合製剤
EP2405900A2 (fr) Nouvelle composition à libération prolongée de composés choisis dans la classe des relaxants musculaires à action centrale
JP2016188181A (ja) ミラベグロン含有放出制御錠剤
KR102479497B1 (ko) 바레니클린 서방성 제제 및 이의 제조 방법
JP3239319B2 (ja) 医薬投与形態の製造法
CN114929207A (zh) 利奥西呱的调节释放型药物组合物
KR20090122344A (ko) 실로스타졸을 함유하는 제어방출 제제 및 이의 제조방법
RS20050835A (sr) Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje
CN112449601B (zh) 含纳呋拉啡口腔崩解片
CN102307575B (zh) 含醋氯芬酸的控释口服药制剂及其制造方法
JP2007520547A (ja) ベンラファキシン塩酸塩の徐放性コーティングされた小型錠剤
JP2009501785A (ja) 新規な調節放出性医薬製剤シクロオキシゲナーゼ酵素阻害剤
JP2018065776A (ja) 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
EP1512394B1 (fr) Composition universelle à libération controlée comprenant du chitosane
CN1720026A (zh) 含有阿夫唑嗪的缓释组合物